Clinical trials for advancing innovative interventions for neurodegenerative diseases
Today: 27/07/2026 · FUTURE · Forthcoming · Viewed
Funding agency: Horizon Europe
Call: HORIZON-HLTH-2027-02-two-stage
Type of action: HORIZON-RIA HORIZON Research and Innovation Actions | Deadline model: two-stage | Planned opening: 10/02/2027 | Model Grant Agreement: HORIZON Action Grant Budget-Based
This call is for clinical trials to advance innovative interventions for neurodegenerative diseases. The proposals will be evaluated blindly and the funding agency may object to a transfer of ownership or exclusive licensing of results.
Budget total: 10000000.0 EUR | Budget per project: — EUR
Deadline: 13/04/2027 (260 days left) | Duration: — months | Funding intensity: 100.0% | Type: research
Eligibility: entity types: research institution, university; countries: EU member states
#neurodegenerative diseases#clinical trials#research and innovation
Health
Matching by organization
"Rule filter" means the score came from a hard eligibility/preference check, not the AI — if that reasoning looks wrong for a specific organization, use Override below to correct it by hand; the system's own score stays visible for comparison and is never silently replaced.
| Organization | Match % | Source | Rationale | Override |
|---|---|---|---|---|
| Novatex Solutions LTD | 0% | Rule filter |
Excluded by eligibility/preference filters: Org type 'SME' not among eligible en…Excluded by eligibility/preference filters: Org type 'SME' not among eligible entity types ['research institution', 'university']. |
Override |
| European Centre for Emerging Competencies and Technologies | 0% | Rule filter |
Excluded by eligibility/preference filters: Org type 'non-profit' not among elig…Excluded by eligibility/preference filters: Org type 'non-profit' not among eligible entity types ['research institution', 'university']. |
Override |